Douglas Burdette

Homogeneous techniques for monitoring receptor-ligand interactions.

J. Marks, Douglas Burdette, D. Giegel, 2002, Methods in molecular biology.

PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases

Douglas Burdette, A. Milici, H. Runnels, 2010, Advances in therapy.

A novel method for assessing inhibition of ibuprofen chiral inversion and its application in drug discovery.

Douglas Burdette, N. Surendran, C. Stankovic, 2007, International journal of pharmaceutics.

Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds.

Caroline A. Lee, Douglas Burdette, R. Hyland, 2008, Journal of pharmacological and toxicological methods.

PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases

Douglas Burdette, A. Milici, H. Runnels, 2010, Advances in therapy.